Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Supportive Care
•
Hematology
•
Stem Cell Transplantation
Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?
Related Questions
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?
What is the preferred treatment for a patient with an EBV+ monomorphic PTLD (DLBCL) not currently on immunosuppressive therapy?
What are your top takeaways from ASH 2023?
Would you offer intensive CNS prophylaxis to Ph negative B-ALL patients who have possible mandibular nerve involvement on MRI face?
For AML patients, when do you stop antiinfective agents?
How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
What is your current approach to maintenance therapy in FLT3-mutant AML post allogeneic HCT?
